|
Buchwalder, A; Welch, S K; Peroutka, S J (1996) Exclusion of 5-HT2A and 5-HT2C receptor genes as candidate genes for migraine. Headache 36:254-8
|
|
Pierce, P A; Xie, G X; Levine, J D et al. (1996) 5-Hydroxytryptamine receptor subtype messenger RNAs in rat peripheral sensory and sympathetic ganglia: a polymerase chain reaction study. Neuroscience 70:553-9
|
|
Guan, X M; Peroutka, S J; Kobilka, B K (1992) Identification of a single amino acid residue responsible for the binding of a class of beta-adrenergic receptor antagonists to 5-hydroxytryptamine1A receptors. Mol Pharmacol 41:695-8
|
|
Pierce, P A; Kim, J Y; Peroutka, S J (1992) Molecular structural basis of ligand selectivity for 5-HT2 versus 5-HT1C cortical receptors. Naunyn Schmiedebergs Arch Pharmacol 346:4-11
|
|
Peroutka, S J (1991) Serotonin receptor subtypes and neuropsychiatric diseases: focus on 5-HT1D and 5-HT3 receptor agents. Pharmacol Rev 43:579-86
|
|
Peroutka, S J; McCarthy, B G; Guan, X M (1991) 5-benzyloxytryptamine: a relatively selective 5-hydroxytryptamine 1D/1B agent. Life Sci 49:409-18
|
|
Liau, L M; Sleight, A J; Pitha, J et al. (1991) Characterization of a novel and potent 5-hydroxytryptamine1A receptor antagonist. Pharmacol Biochem Behav 38:555-9
|
|
Sleight, A J; Peroutka, S J (1991) Identification of 5-hydroxytryptamine1A receptor agents using a composite pharmacophore analysis and chemical database screening. Naunyn Schmiedebergs Arch Pharmacol 343:109-16
|
|
McKenna, D J; Guan, X M; Shulgin, A T (1991) 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine. Pharmacol Biochem Behav 38:505-12
|
|
Gonzalez-Heydrich, J; Peroutka, S J (1991) Postsynaptic localization of 5-HT1D receptor binding sites in human caudate. Exp Neurol 113:28-30
|
Showing the most recent 10 out of 51 publications
